CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM - HORIZON THERAPEUTICS PUB L ownership

HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 522 filers reported holding HORIZON THERAPEUTICS PUB L in Q2 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.

Quarter-by-quarter ownership
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM ownership history of HORIZON THERAPEUTICS PUB L
ValueSharesWeighting
Q3 2023$40,188,392
+7.7%
347,380
-4.2%
0.06%
+17.0%
Q2 2023$37,303,386
-6.7%
362,697
-1.0%
0.05%
-10.2%
Q1 2023$39,971,979
-3.8%
366,245
+0.3%
0.06%
-9.2%
Q4 2022$41,565,791
+86.7%
365,253
+1.5%
0.06%
+71.1%
Q3 2022$22,264,000
-24.6%
359,734
-2.8%
0.04%
-19.1%
Q2 2022$29,532,000
-23.6%
370,262
+0.8%
0.05%
-7.8%
Q1 2022$38,660,000
-7.7%
367,451
-5.5%
0.05%
+4.1%
Q4 2021$41,903,000
-0.2%
388,851
+1.4%
0.05%
-9.3%
Q3 2021$42,002,000
+16.8%
383,444
-0.1%
0.05%
+20.0%
Q2 2021$35,947,000
+2.1%
383,890
+0.4%
0.04%
-4.3%
Q1 2021$35,202,000
+27.5%
382,460
+1.3%
0.05%
+20.5%
Q4 2020$27,607,000
+3.5%
377,408
+9.9%
0.04%
-9.3%
Q3 2020$26,669,000
+52.0%
343,320
+8.7%
0.04%
+38.7%
Q2 2020$17,547,000
+90.9%
315,706
+1.7%
0.03%
+55.0%
Q1 2020$9,194,000
-13.0%
310,390
+6.3%
0.02%
+11.1%
Q4 2019$10,569,000
+32.5%
291,958
-0.3%
0.02%
+12.5%
Q3 2019$7,976,000
+13.6%
292,915
+0.4%
0.02%
+14.3%
Q2 2019$7,021,000291,8200.01%
Other shareholders
HORIZON THERAPEUTICS PUB L shareholders Q2 2021
NameSharesValueWeighting ↓
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,462,634$175,978,0007.18%
SCOPIA CAPITAL MANAGEMENT LP 4,221,585$114,954,0006.73%
JW Asset Management, LLC 270,775$7,373,0006.49%
KOPP INVESTMENT ADVISORS LLC 104,462$2,845,0005.23%
1492 Capital Management LLC 171,621$4,673,0004.56%
Avoro Capital Advisors LLC 4,000,000$108,920,0004.54%
Paulson & Co. 8,170,700$222,488,0004.46%
Rhenman & Partners Asset Management AB 1,025,000$27,911,0003.50%
Redwood Investments, LLC 1,376,066$37,470,0002.88%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 218,000$5,938,0002.74%
View complete list of HORIZON THERAPEUTICS PUB L shareholders